2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( Part 1A – Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine)
Bioanalysis · 2023
DOI: 10.4155/bio-2023-0167 ↗Kurz gefasst
Leitlinie in der Zeitschrift Bioanalysis, 2023. Verfasst von Matt Szapacs und 59 weiteren Autor:innen. Beteiligte Einrichtung: Abbvie, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Chromatography, Vaccines. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 94 Literaturangaben. Gefördert von: World Health Organization.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Abbvie, Philadelphia, PA, USA.
- Janssen, Spring House, PA, USA.
- Merck, West Point, PA, USA.
- Novartis, Cambridge, MA, USA.
- Lilly, Indianapolis, IN, USA.
- Genentech, South San Francisco, CA, USA.
Förderung
- World Health Organization
Zitieren
APA
Szapacs, M., Jian, W., Spellman, D., Cunliffe, J., Verburg, E., Kaur, S., Kellie, J., Li, W., Mehl, J., Qian, M., Qiu, X., Sirtori, F. R., Rosenbaum, A. I., Sikorski, T., Surapaneni, S., Wang, J., Wilson, A., Zhang, J., Xue, Y., …, & Wan, K. (2023). 2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( Part 1A – Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine). Bioanalysis. https://doi.org/10.4155/bio-2023-0167
Vancouver
Szapacs M, Jian W, Spellman D, Cunliffe J, Verburg E, Kaur S, et al. 2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( Part 1A – Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine). Bioanalysis. 2023. doi:10.4155/bio-2023-0167
BibTeX
@article{Szapacs2023,
author = {Szapacs, Matt and Jian, Wenying and Spellman, Daniel and Cunliffe, Jennifer and Verburg, Elizabeth and Kaur, Surinder and Kellie, John and Li, Wenkui and Mehl, John and Qian, Mark and Qiu, Xiazi and Sirtori, Federico Riccardi and Rosenbaum, Anton I and Sikorski, Tim and Surapaneni, Sekhar and Wang, Jian and Wilson, Amanda and Zhang, Jinhui and Xue, Yongjun and Post, Noah and Huang, Yue and Goykhman, Dina and Yuan, Long and Fang, Kasie and Casavant, Ellen and Chen, Linzhi and Fu, Yunlin and Huang, Ming and Ji, Allena and Johnson, Jay and Lassman, Michael and Li, Jing and Saad, Ola and Sarvaiya, Hetal and Tao, Lin and Wang, Yuting and Zheng, Naiyu and Dasgupta, Arindam and Abhari, Mohsen Rajabi and Ishii-Watabe, Akiko and Saito, Yoshiro and Mendes Fernandes, Dulcyane Neiva and Bower, Joseph and Burns, Chris and Carleton, Kevin and Cho, Seongeun Julia and Du, Xiulian and Fjording, Marianne and Garofolo, Fabio and Kar, Sumit and Kavetska, Olga and Kossary, Elham and Lu, Yang and Mayer, Andrew and Palackal, Nisha and Salha, Danielle and Thomas, Eric and Verhaeghe, Tom and Vinter, Stephen and Wan, Katty},
title = {2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( Part 1A – Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine)},
journal = {Bioanalysis},
year = {2023},
doi = {10.4155/bio-2023-0167}
}
EUVIMED